416 related articles for article (PubMed ID: 166157)
1. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
Cubeddu L; Barnes E; Weiner N
J Pharmacol Exp Ther; 1975 Apr; 193(1):105-27. PubMed ID: 166157
[TBL] [Abstract][Full Text] [Related]
2. Nerve stimulation-meditated overflow of norepinephrine and dopamine-beta-hydroxylase. III. Effects of norepinephrine depletion on the alpha presynaptic regulation of release.
Cubeddu L; Weiner N
J Pharmacol Exp Ther; 1975 Jan; 192(1):1-14. PubMed ID: 235629
[TBL] [Abstract][Full Text] [Related]
3. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. V. Enhanced release associated with a granular effect of a benzoquinolizine derivative with reserpine-like properties.
Cubeddu LX; Weiner N
J Pharmacol Exp Ther; 1975 Jun; 193(3):757-75. PubMed ID: 239214
[TBL] [Abstract][Full Text] [Related]
4. Enhanced exocytotic release of norepinephrine consequent to nerve stimulation by low concentrations of cyclic nucleotides in the presence of phenoxy-benzamine.
Langley AE; Weiner N
J Pharmacol Exp Ther; 1978 May; 205(2):426-37. PubMed ID: 641838
[TBL] [Abstract][Full Text] [Related]
5. The effect of pargyline pretreatment on the enhancement of the exocytotic release of norepinephrine during nerve stimulation which is induced by a benzoquinolizine compound with reserpine-like properties.
Langley AE; Weiner N
J Pharmacol Exp Ther; 1980 Jun; 213(3):534-8. PubMed ID: 6907314
[TBL] [Abstract][Full Text] [Related]
6. Influence of the frequency of nerve stimulation on the metabolism of 3H-norepinephrine released from the perfused cat spleen: differences observed during and after the period of stimulation.
Dubocovich ML; Langer SZ
J Pharmacol Exp Ther; 1976 Jul; 198(1):83-101. PubMed ID: 933013
[TBL] [Abstract][Full Text] [Related]
7. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. II. Effects of papaverine.
Cubeddu L; Barnes E; Weiner N
J Pharmacol Exp Ther; 1974 Dec; 191(3):444-57. PubMed ID: 4372339
[No Abstract] [Full Text] [Related]
8. Norepinephrine release and vascular response elicited by nerve stimulation in rats with chronic neurogenic hypertension.
Granata AR; Enero MA; Krieger EM; Langer SZ
J Pharmacol Exp Ther; 1983 Oct; 227(1):187-93. PubMed ID: 6312017
[TBL] [Abstract][Full Text] [Related]
9. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors.
Cubeddu L; Barnes EM; Langer SZ; Weiner N
J Pharmacol Exp Ther; 1974 Sep; 190(3):431-50. PubMed ID: 4153469
[No Abstract] [Full Text] [Related]
10. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of release of norepinephrine from cat spleen slices by sodium deprivation and calcium pretreatment.
Garcia AG; Kirpekar SM
J Pharmacol Exp Ther; 1975 Feb; 192(2):343-50. PubMed ID: 1117422
[TBL] [Abstract][Full Text] [Related]
12. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
Miot F; Erneux C; Wells JN; Dumont JE
Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
[TBL] [Abstract][Full Text] [Related]
13. Modulation of peripheral adrenergic neurotransmission by methionine-enkephalin.
Gaddis RR; Dixon WR
J Pharmacol Exp Ther; 1982 May; 221(2):282-8. PubMed ID: 6281410
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
[TBL] [Abstract][Full Text] [Related]
15. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-beta-hydroxylase: a modulator of beta adrenergic receptor activity.
Thomas JA; Sakai KK; Holck MI; Marks BH
Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):3-13. PubMed ID: 6250208
[TBL] [Abstract][Full Text] [Related]
17. Regulation of isoproterenol-induced cyclic AMP accumulation in LRM55 glial cells by phosphodiesterase.
Madelian V; Shain W
J Pharmacol Exp Ther; 1987 Nov; 243(2):618-23. PubMed ID: 2445955
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors.
Rapp NS; Zenser TV; Mattammal MB; Davis BB
J Pharmacol Exp Ther; 1981 Nov; 219(2):442-6. PubMed ID: 6169824
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyclic AMP analogues and phosphodiesterase inhibitors on K+-induced [3H]noradrenaline release from rat brain slices and on its presynaptic alpha-adrenergic modulation.
Wemer J; Schoffelmeer AN; Mulder AH
J Neurochem; 1982 Aug; 39(2):349-56. PubMed ID: 6283025
[TBL] [Abstract][Full Text] [Related]
20. Role of cyclic AMP in the prejunctional alpha 2-adrenoceptor modulation of noradrenaline release from the rat tail artery.
Bucher B; Pain L; Stoclet JC; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):640-9. PubMed ID: 1965731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
